nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcipotriol—Vitamin D—Cholecalciferol—psoriasis	0.308	1	CiPCiCtD
Calcipotriol—Calcitriol—psoriasis	0.127	0.54	CrCtD
Calcipotriol—VDR—psoriasis	0.112	1	CbGaD
Calcipotriol—Cholecalciferol—psoriasis	0.108	0.46	CrCtD
Calcipotriol—CYP24A1—Calcitriol—psoriasis	0.0648	0.454	CbGbCtD
Calcipotriol—VDR—Calcitriol—psoriasis	0.0515	0.36	CbGbCtD
Calcipotriol—VDR—Cholecalciferol—psoriasis	0.0265	0.186	CbGbCtD
Calcipotriol—Paricalcitol—Calcitriol—psoriasis	0.0142	0.0901	CrCrCtD
Calcipotriol—Cholecalciferol—Calcitriol—psoriasis	0.0142	0.0901	CrCrCtD
Calcipotriol—Alfacalcidol—Calcitriol—psoriasis	0.0142	0.0901	CrCrCtD
Calcipotriol—Ergocalciferol—Calcitriol—psoriasis	0.0142	0.0901	CrCrCtD
Calcipotriol—Dihydrotachysterol—Calcitriol—psoriasis	0.0142	0.0901	CrCrCtD
Calcipotriol—Calcidiol—Calcitriol—psoriasis	0.0142	0.0901	CrCrCtD
Calcipotriol—Alfacalcidol—Cholecalciferol—psoriasis	0.0121	0.0766	CrCrCtD
Calcipotriol—Ergocalciferol—Cholecalciferol—psoriasis	0.0121	0.0766	CrCrCtD
Calcipotriol—Calcitriol—Cholecalciferol—psoriasis	0.0121	0.0766	CrCrCtD
Calcipotriol—Paricalcitol—Cholecalciferol—psoriasis	0.0121	0.0766	CrCrCtD
Calcipotriol—Dihydrotachysterol—Cholecalciferol—psoriasis	0.0121	0.0766	CrCrCtD
Calcipotriol—Calcidiol—Cholecalciferol—psoriasis	0.0121	0.0766	CrCrCtD
Calcipotriol—Application site erythema—Tazarotene—psoriasis	0.00156	0.0512	CcSEcCtD
Calcipotriol—VDR—vertebral column—psoriasis	0.00142	0.403	CbGeAlD
Calcipotriol—Localized exfoliation—Tazarotene—psoriasis	0.00136	0.0448	CcSEcCtD
Calcipotriol—Instillation site pain—Tazarotene—psoriasis	0.00113	0.037	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL19—psoriasis	0.00111	0.12	CbGpPWpGaD
Calcipotriol—Skin atrophy—Clobetasol propionate—psoriasis	0.00103	0.0339	CcSEcCtD
Calcipotriol—Instillation site pain—Clobetasol propionate—psoriasis	0.000955	0.0314	CcSEcCtD
Calcipotriol—Skin atrophy—Beclomethasone—psoriasis	0.000939	0.0308	CcSEcCtD
Calcipotriol—Skin atrophy—Fluocinonide—psoriasis	0.00093	0.0305	CcSEcCtD
Calcipotriol—VDR—skin epidermis—psoriasis	0.000871	0.247	CbGeAlD
Calcipotriol—Skin irritation—Tazarotene—psoriasis	0.000849	0.0279	CcSEcCtD
Calcipotriol—Application site pain—Tazarotene—psoriasis	0.000835	0.0274	CcSEcCtD
Calcipotriol—Application site pain—Clobetasol propionate—psoriasis	0.000708	0.0232	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL23R—psoriasis	0.000639	0.0689	CbGpPWpGaD
Calcipotriol—Application site pain—Fluocinonide—psoriasis	0.000639	0.021	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Tazarotene—psoriasis	0.000617	0.0203	CcSEcCtD
Calcipotriol—Skin atrophy—Acitretin—psoriasis	0.000582	0.0191	CcSEcCtD
Calcipotriol—Skin atrophy—Fluocinolone Acetonide—psoriasis	0.00058	0.0191	CcSEcCtD
Calcipotriol—CYP24A1—Vitamin D Metabolism—VDR—psoriasis	0.000553	0.0597	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—IL23A—psoriasis	0.000543	0.0586	CbGpPWpGaD
Calcipotriol—MPO—endothelium—psoriasis	0.000533	0.151	CbGeAlD
Calcipotriol—Skin hyperpigmentation—Clobetasol propionate—psoriasis	0.000523	0.0172	CcSEcCtD
Calcipotriol—Folliculitis—Clobetasol propionate—psoriasis	0.000495	0.0163	CcSEcCtD
Calcipotriol—Skin atrophy—Hydroxyurea—psoriasis	0.000457	0.015	CcSEcCtD
Calcipotriol—Stinging—Tazarotene—psoriasis	0.000453	0.0149	CcSEcCtD
Calcipotriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000453	0.0488	CbGpPWpGaD
Calcipotriol—Folliculitis—Fluocinonide—psoriasis	0.000447	0.0147	CcSEcCtD
Calcipotriol—CYP24A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000447	0.0482	CbGpPWpGaD
Calcipotriol—Skin irritation—Acitretin—psoriasis	0.000406	0.0133	CcSEcCtD
Calcipotriol—Skin irritation—Fluocinolone Acetonide—psoriasis	0.000405	0.0133	CcSEcCtD
Calcipotriol—Tingling sensation—Clobetasol propionate—psoriasis	0.000387	0.0127	CcSEcCtD
Calcipotriol—Stinging—Clobetasol propionate—psoriasis	0.000384	0.0126	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Methoxsalen—psoriasis	0.000373	0.0122	CcSEcCtD
Calcipotriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000367	0.0396	CbGpPWpGaD
Calcipotriol—Folliculitis—Methoxsalen—psoriasis	0.000353	0.0116	CcSEcCtD
Calcipotriol—Skin exfoliation—Tazarotene—psoriasis	0.000351	0.0115	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Fluocinolone Acetonide—psoriasis	0.000295	0.00968	CcSEcCtD
Calcipotriol—Localized exfoliation—Triamcinolone—psoriasis	0.000291	0.00954	CcSEcCtD
Calcipotriol—Hypercalcaemia—Calcitriol—psoriasis	0.000284	0.00934	CcSEcCtD
Calcipotriol—Folliculitis—Fluocinolone Acetonide—psoriasis	0.000279	0.00916	CcSEcCtD
Calcipotriol—Skin atrophy—Hydrocortisone—psoriasis	0.000275	0.00904	CcSEcCtD
Calcipotriol—Dihydrotachysterol—VDR—psoriasis	0.000274	0.236	CrCbGaD
Calcipotriol—VDR—skin of body—psoriasis	0.00027	0.0765	CbGeAlD
Calcipotriol—Skin exfoliation—Fluocinonide—psoriasis	0.000268	0.0088	CcSEcCtD
Calcipotriol—Skin atrophy—Triamcinolone—psoriasis	0.000259	0.00851	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL17A—psoriasis	0.000254	0.0274	CbGpPWpGaD
Calcipotriol—Dry skin—Tazarotene—psoriasis	0.000244	0.00802	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL12B—psoriasis	0.000236	0.0255	CbGpPWpGaD
Calcipotriol—Skin atrophy—Dexamethasone—psoriasis	0.000235	0.00772	CcSEcCtD
Calcipotriol—Skin atrophy—Betamethasone—psoriasis	0.000235	0.00772	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Hydroxyurea—psoriasis	0.000232	0.00762	CcSEcCtD
Calcipotriol—MPO—skin of body—psoriasis	0.000228	0.0645	CbGeAlD
Calcipotriol—Skin exfoliation—Methoxsalen—psoriasis	0.000212	0.00695	CcSEcCtD
Calcipotriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000208	0.0224	CbGpPWpGaD
Calcipotriol—Dry skin—Clobetasol propionate—psoriasis	0.000207	0.0068	CcSEcCtD
Calcipotriol—VDR—tendon—psoriasis	0.000205	0.0582	CbGeAlD
Calcipotriol—Skin atrophy—Prednisone—psoriasis	0.000205	0.00672	CcSEcCtD
Calcipotriol—CYP24A1—Biological oxidations—CYP2S1—psoriasis	0.000195	0.021	CbGpPWpGaD
Calcipotriol—CYP24A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000192	0.0207	CbGpPWpGaD
Calcipotriol—Skin irritation—Hydrocortisone—psoriasis	0.000192	0.00631	CcSEcCtD
Calcipotriol—Application site pain—Hydrocortisone—psoriasis	0.000189	0.0062	CcSEcCtD
Calcipotriol—Dry skin—Fluocinonide—psoriasis	0.000187	0.00614	CcSEcCtD
Calcipotriol—Alfacalcidol—VDR—psoriasis	0.000177	0.152	CrCbGaD
Calcipotriol—Calcidiol—VDR—psoriasis	0.000177	0.152	CrCbGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000171	0.0185	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Acitretin—psoriasis	0.000168	0.00551	CcSEcCtD
Calcipotriol—Hypercalcaemia—Mycophenolic acid—psoriasis	0.000166	0.00546	CcSEcCtD
Calcipotriol—Erythema—Tazarotene—psoriasis	0.000161	0.00527	CcSEcCtD
Calcipotriol—Calcitriol—VDR—psoriasis	0.000157	0.135	CrCbGaD
Calcipotriol—Paricalcitol—VDR—psoriasis	0.000157	0.135	CrCbGaD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.000151	0.0162	CbGpPWpGaD
Calcipotriol—Folliculitis—Cyclosporine—psoriasis	0.000149	0.00488	CcSEcCtD
Calcipotriol—Dry skin—Methoxsalen—psoriasis	0.000147	0.00484	CcSEcCtD
Calcipotriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000145	0.0156	CbGpPWpGaD
Calcipotriol—Skin hyperpigmentation—Hydrocortisone—psoriasis	0.00014	0.00459	CcSEcCtD
Calcipotriol—Erythema—Clobetasol propionate—psoriasis	0.000136	0.00447	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—NOS2—psoriasis	0.000133	0.0143	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—NFKBIA—psoriasis	0.000133	0.0143	CbGpPWpGaD
Calcipotriol—Folliculitis—Hydrocortisone—psoriasis	0.000132	0.00434	CcSEcCtD
Calcipotriol—Skin exfoliation—Hydroxyurea—psoriasis	0.000132	0.00433	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Triamcinolone—psoriasis	0.000132	0.00432	CcSEcCtD
Calcipotriol—Hypercalcaemia—Mycophenolate mofetil—psoriasis	0.000131	0.00431	CcSEcCtD
Calcipotriol—Ergocalciferol—VDR—psoriasis	0.000126	0.108	CrCbGaD
Calcipotriol—Folliculitis—Triamcinolone—psoriasis	0.000124	0.00409	CcSEcCtD
Calcipotriol—Erythema—Fluocinonide—psoriasis	0.000123	0.00403	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000121	0.0131	CbGpPWpGaD
Calcipotriol—Skin hyperpigmentation—Dexamethasone—psoriasis	0.000119	0.00392	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Betamethasone—psoriasis	0.000119	0.00392	CcSEcCtD
Calcipotriol—Dry skin—Acitretin—psoriasis	0.000117	0.00384	CcSEcCtD
Calcipotriol—Tingling sensation—Cyclosporine—psoriasis	0.000116	0.00382	CcSEcCtD
Calcipotriol—Stinging—Cyclosporine—psoriasis	0.000115	0.00379	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—CAT—psoriasis	0.000115	0.0124	CbGpPWpGaD
Calcipotriol—Folliculitis—Dexamethasone—psoriasis	0.000113	0.00371	CcSEcCtD
Calcipotriol—Folliculitis—Betamethasone—psoriasis	0.000113	0.00371	CcSEcCtD
Calcipotriol—MPO—Vitamin B12 Metabolism—CRP—psoriasis	0.000112	0.0121	CbGpPWpGaD
Calcipotriol—Pain—Tazarotene—psoriasis	0.000112	0.00368	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptors—PPARG—psoriasis	0.000111	0.012	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—APOE—psoriasis	0.00011	0.0119	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—TYK2—psoriasis	0.000109	0.0117	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—IL4—psoriasis	0.000106	0.0114	CbGpPWpGaD
Calcipotriol—Stinging—Prednisolone—psoriasis	0.000105	0.00345	CcSEcCtD
Calcipotriol—Tingling sensation—Hydrocortisone—psoriasis	0.000103	0.00339	CcSEcCtD
Calcipotriol—MPO—Vitamin B12 Metabolism—ICAM1—psoriasis	0.000103	0.0112	CbGpPWpGaD
Calcipotriol—Stinging—Hydrocortisone—psoriasis	0.000103	0.00337	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IFNG—psoriasis	0.000102	0.011	CbGpPWpGaD
Calcipotriol—Paraesthesia—Clobetasol propionate—psoriasis	9.97e-05	0.00328	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—CD4—psoriasis	9.82e-05	0.0106	CbGpPWpGaD
Calcipotriol—Erythema—Methoxsalen—psoriasis	9.69e-05	0.00318	CcSEcCtD
Calcipotriol—Stinging—Triamcinolone—psoriasis	9.66e-05	0.00317	CcSEcCtD
Calcipotriol—Cholecalciferol—VDR—psoriasis	9.54e-05	0.082	CrCbGaD
Calcipotriol—Pain—Clobetasol propionate—psoriasis	9.5e-05	0.00312	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—CARM1—psoriasis	9.4e-05	0.0101	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—TGFA—psoriasis	9.4e-05	0.0101	CbGpPWpGaD
Calcipotriol—Pruritus—Tazarotene—psoriasis	9.27e-05	0.00304	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—CAT—psoriasis	9.15e-05	0.00988	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—CRP—psoriasis	9.15e-05	0.00987	CbGpPWpGaD
Calcipotriol—Tingling sensation—Dexamethasone—psoriasis	8.83e-05	0.0029	CcSEcCtD
Calcipotriol—Tingling sensation—Betamethasone—psoriasis	8.83e-05	0.0029	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptor transcription pathway—PPARG—psoriasis	8.78e-05	0.00947	CbGpPWpGaD
Calcipotriol—Stinging—Dexamethasone—psoriasis	8.76e-05	0.00288	CcSEcCtD
Calcipotriol—Stinging—Betamethasone—psoriasis	8.76e-05	0.00288	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Methotrexate—psoriasis	8.69e-05	0.00285	CcSEcCtD
Calcipotriol—Pain—Beclomethasone—psoriasis	8.65e-05	0.00284	CcSEcCtD
Calcipotriol—Erythema—Calcitriol—psoriasis	8.64e-05	0.00284	CcSEcCtD
Calcipotriol—Pain—Fluocinonide—psoriasis	8.57e-05	0.00281	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	8.46e-05	0.00913	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—NFKB1—psoriasis	8.46e-05	0.00913	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—ICAM1—psoriasis	8.41e-05	0.00907	CbGpPWpGaD
Calcipotriol—Rash—Tazarotene—psoriasis	8.26e-05	0.00271	CcSEcCtD
Calcipotriol—Dermatitis—Tazarotene—psoriasis	8.25e-05	0.00271	CcSEcCtD
Calcipotriol—Folliculitis—Methotrexate—psoriasis	8.22e-05	0.0027	CcSEcCtD
Calcipotriol—Hypersensitivity—Clobetasol propionate—psoriasis	8.18e-05	0.00269	CcSEcCtD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	7.99e-05	0.00863	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Hydrocortisone—psoriasis	7.93e-05	0.00261	CcSEcCtD
Calcipotriol—MPO—Vitamin B12 Metabolism—IFNG—psoriasis	7.86e-05	0.00848	CbGpPWpGaD
Calcipotriol—Pruritus—Clobetasol propionate—psoriasis	7.86e-05	0.00258	CcSEcCtD
Calcipotriol—Erythema—Acitretin—psoriasis	7.68e-05	0.00252	CcSEcCtD
Calcipotriol—Erythema—Fluocinolone Acetonide—psoriasis	7.66e-05	0.00252	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—STAT3—psoriasis	7.6e-05	0.0082	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Triamcinolone—psoriasis	7.47e-05	0.00245	CcSEcCtD
Calcipotriol—Hypersensitivity—Fluocinonide—psoriasis	7.38e-05	0.00242	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—CRP—psoriasis	7.27e-05	0.00784	CbGpPWpGaD
Calcipotriol—Pruritus—Fluocinonide—psoriasis	7.09e-05	0.00233	CcSEcCtD
Calcipotriol—Rash—Clobetasol propionate—psoriasis	7e-05	0.0023	CcSEcCtD
Calcipotriol—Dermatitis—Clobetasol propionate—psoriasis	7e-05	0.0023	CcSEcCtD
Calcipotriol—Skin exfoliation—Betamethasone—psoriasis	6.78e-05	0.00223	CcSEcCtD
Calcipotriol—Skin exfoliation—Dexamethasone—psoriasis	6.78e-05	0.00223	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—ICAM1—psoriasis	6.68e-05	0.00721	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—TNF—psoriasis	6.58e-05	0.0071	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—NFKB1—psoriasis	6.54e-05	0.00706	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—IFNG—psoriasis	6.4e-05	0.0069	CbGpPWpGaD
Calcipotriol—Rash—Beclomethasone—psoriasis	6.38e-05	0.00209	CcSEcCtD
Calcipotriol—Dermatitis—Beclomethasone—psoriasis	6.37e-05	0.00209	CcSEcCtD
Calcipotriol—Rash—Fluocinonide—psoriasis	6.32e-05	0.00207	CcSEcCtD
Calcipotriol—Dermatitis—Fluocinonide—psoriasis	6.31e-05	0.00207	CcSEcCtD
Calcipotriol—Dry skin—Cyclosporine—psoriasis	6.22e-05	0.00204	CcSEcCtD
Calcipotriol—Erythema—Hydroxyurea—psoriasis	6.03e-05	0.00198	CcSEcCtD
Calcipotriol—Pain—Calcitriol—psoriasis	6.03e-05	0.00198	CcSEcCtD
Calcipotriol—Skin exfoliation—Prednisone—psoriasis	5.9e-05	0.00194	CcSEcCtD
Calcipotriol—Hypersensitivity—Methoxsalen—psoriasis	5.83e-05	0.00191	CcSEcCtD
Calcipotriol—Dry skin—Prednisolone—psoriasis	5.66e-05	0.00186	CcSEcCtD
Calcipotriol—Paraesthesia—Acitretin—psoriasis	5.63e-05	0.00185	CcSEcCtD
Calcipotriol—Pruritus—Methoxsalen—psoriasis	5.6e-05	0.00184	CcSEcCtD
Calcipotriol—VDR—Gene Expression—TARS—psoriasis	5.57e-05	0.00601	CbGpPWpGaD
Calcipotriol—Dry skin—Hydrocortisone—psoriasis	5.53e-05	0.00182	CcSEcCtD
Calcipotriol—Pain—Acitretin—psoriasis	5.36e-05	0.00176	CcSEcCtD
Calcipotriol—Pain—Fluocinolone Acetonide—psoriasis	5.35e-05	0.00176	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—NFKB1—psoriasis	5.32e-05	0.00574	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—IL6—psoriasis	5.31e-05	0.00573	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Calcitriol—psoriasis	5.19e-05	0.00171	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—CD4—psoriasis	5.09e-05	0.0055	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—TNF—psoriasis	5.09e-05	0.00549	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—IFNG—psoriasis	5.08e-05	0.00548	CbGpPWpGaD
Calcipotriol—Pruritus—Calcitriol—psoriasis	4.99e-05	0.00164	CcSEcCtD
Calcipotriol—Rash—Methoxsalen—psoriasis	4.99e-05	0.00164	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—PCNA—psoriasis	4.98e-05	0.00538	CbGpPWpGaD
Calcipotriol—Dermatitis—Methoxsalen—psoriasis	4.98e-05	0.00164	CcSEcCtD
Calcipotriol—Skin exfoliation—Methotrexate—psoriasis	4.93e-05	0.00162	CcSEcCtD
Calcipotriol—Dry skin—Dexamethasone—psoriasis	4.72e-05	0.00155	CcSEcCtD
Calcipotriol—Dry skin—Betamethasone—psoriasis	4.72e-05	0.00155	CcSEcCtD
Calcipotriol—Hypersensitivity—Acitretin—psoriasis	4.62e-05	0.00152	CcSEcCtD
Calcipotriol—Hypersensitivity—Fluocinolone Acetonide—psoriasis	4.61e-05	0.00151	CcSEcCtD
Calcipotriol—Rash—Calcitriol—psoriasis	4.44e-05	0.00146	CcSEcCtD
Calcipotriol—Dermatitis—Calcitriol—psoriasis	4.44e-05	0.00146	CcSEcCtD
Calcipotriol—Pruritus—Acitretin—psoriasis	4.44e-05	0.00146	CcSEcCtD
Calcipotriol—Pruritus—Fluocinolone Acetonide—psoriasis	4.42e-05	0.00145	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	4.3e-05	0.00464	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—NFKB1—psoriasis	4.23e-05	0.00456	CbGpPWpGaD
Calcipotriol—Pain—Hydroxyurea—psoriasis	4.21e-05	0.00138	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—TNF—psoriasis	4.14e-05	0.00447	CbGpPWpGaD
Calcipotriol—Dry skin—Prednisone—psoriasis	4.11e-05	0.00135	CcSEcCtD
Calcipotriol—MPO—Vitamin B12 Metabolism—IL6—psoriasis	4.11e-05	0.00443	CbGpPWpGaD
Calcipotriol—Rash—Acitretin—psoriasis	3.95e-05	0.0013	CcSEcCtD
Calcipotriol—Dermatitis—Acitretin—psoriasis	3.95e-05	0.0013	CcSEcCtD
Calcipotriol—Rash—Fluocinolone Acetonide—psoriasis	3.94e-05	0.00129	CcSEcCtD
Calcipotriol—Dermatitis—Fluocinolone Acetonide—psoriasis	3.94e-05	0.00129	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—NDUFA5—psoriasis	3.92e-05	0.00423	CbGpPWpGaD
Calcipotriol—Erythema—Prednisolone—psoriasis	3.72e-05	0.00122	CcSEcCtD
Calcipotriol—Paraesthesia—Mycophenolic acid—psoriasis	3.7e-05	0.00122	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.65e-05	0.00394	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—TP53—psoriasis	3.65e-05	0.00394	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—CARM1—psoriasis	3.64e-05	0.00393	CbGpPWpGaD
Calcipotriol—Erythema—Hydrocortisone—psoriasis	3.63e-05	0.00119	CcSEcCtD
Calcipotriol—Hypersensitivity—Hydroxyurea—psoriasis	3.63e-05	0.00119	CcSEcCtD
Calcipotriol—Pain—Mycophenolic acid—psoriasis	3.53e-05	0.00116	CcSEcCtD
Calcipotriol—Erythema—Triamcinolone—psoriasis	3.42e-05	0.00112	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—IL6—psoriasis	3.34e-05	0.00361	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CYP2S1—psoriasis	3.33e-05	0.0036	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—TNF—psoriasis	3.29e-05	0.00355	CbGpPWpGaD
Calcipotriol—Rash—Hydroxyurea—psoriasis	3.1e-05	0.00102	CcSEcCtD
Calcipotriol—Erythema—Dexamethasone—psoriasis	3.1e-05	0.00102	CcSEcCtD
Calcipotriol—Erythema—Betamethasone—psoriasis	3.1e-05	0.00102	CcSEcCtD
Calcipotriol—Dermatitis—Hydroxyurea—psoriasis	3.1e-05	0.00102	CcSEcCtD
Calcipotriol—Paraesthesia—Cyclosporine—psoriasis	3e-05	0.000984	CcSEcCtD
Calcipotriol—Paraesthesia—Mycophenolate mofetil—psoriasis	2.92e-05	0.00096	CcSEcCtD
Calcipotriol—Pruritus—Mycophenolic acid—psoriasis	2.92e-05	0.000958	CcSEcCtD
Calcipotriol—Pain—Cyclosporine—psoriasis	2.85e-05	0.000937	CcSEcCtD
Calcipotriol—Pain—Mycophenolate mofetil—psoriasis	2.78e-05	0.000914	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—JUN—psoriasis	2.78e-05	0.003	CbGpPWpGaD
Calcipotriol—Paraesthesia—Prednisolone—psoriasis	2.73e-05	0.000895	CcSEcCtD
Calcipotriol—Erythema—Prednisone—psoriasis	2.7e-05	0.000888	CcSEcCtD
Calcipotriol—Paraesthesia—Hydrocortisone—psoriasis	2.66e-05	0.000874	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—IL6—psoriasis	2.65e-05	0.00286	CbGpPWpGaD
Calcipotriol—Rash—Mycophenolic acid—psoriasis	2.6e-05	0.000854	CcSEcCtD
Calcipotriol—Dermatitis—Mycophenolic acid—psoriasis	2.6e-05	0.000853	CcSEcCtD
Calcipotriol—Pain—Prednisolone—psoriasis	2.6e-05	0.000852	CcSEcCtD
Calcipotriol—Pain—Hydrocortisone—psoriasis	2.54e-05	0.000832	CcSEcCtD
Calcipotriol—Paraesthesia—Triamcinolone—psoriasis	2.51e-05	0.000823	CcSEcCtD
Calcipotriol—Hypersensitivity—Cyclosporine—psoriasis	2.46e-05	0.000807	CcSEcCtD
Calcipotriol—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.4e-05	0.000787	CcSEcCtD
Calcipotriol—Pain—Triamcinolone—psoriasis	2.39e-05	0.000784	CcSEcCtD
Calcipotriol—Pruritus—Cyclosporine—psoriasis	2.36e-05	0.000775	CcSEcCtD
Calcipotriol—Pruritus—Mycophenolate mofetil—psoriasis	2.3e-05	0.000756	CcSEcCtD
Calcipotriol—Paraesthesia—Betamethasone—psoriasis	2.27e-05	0.000747	CcSEcCtD
Calcipotriol—Paraesthesia—Dexamethasone—psoriasis	2.27e-05	0.000747	CcSEcCtD
Calcipotriol—Erythema—Methotrexate—psoriasis	2.26e-05	0.000742	CcSEcCtD
Calcipotriol—Hypersensitivity—Prednisolone—psoriasis	2.24e-05	0.000734	CcSEcCtD
Calcipotriol—Hypersensitivity—Hydrocortisone—psoriasis	2.18e-05	0.000717	CcSEcCtD
Calcipotriol—Pain—Betamethasone—psoriasis	2.17e-05	0.000711	CcSEcCtD
Calcipotriol—Pain—Dexamethasone—psoriasis	2.17e-05	0.000711	CcSEcCtD
Calcipotriol—Rash—Cyclosporine—psoriasis	2.1e-05	0.000691	CcSEcCtD
Calcipotriol—Dermatitis—Cyclosporine—psoriasis	2.1e-05	0.00069	CcSEcCtD
Calcipotriol—Pruritus—Hydrocortisone—psoriasis	2.1e-05	0.000689	CcSEcCtD
Calcipotriol—Hypersensitivity—Triamcinolone—psoriasis	2.06e-05	0.000675	CcSEcCtD
Calcipotriol—Rash—Mycophenolate mofetil—psoriasis	2.05e-05	0.000674	CcSEcCtD
Calcipotriol—Dermatitis—Mycophenolate mofetil—psoriasis	2.05e-05	0.000673	CcSEcCtD
Calcipotriol—Paraesthesia—Prednisone—psoriasis	1.98e-05	0.00065	CcSEcCtD
Calcipotriol—Pruritus—Triamcinolone—psoriasis	1.97e-05	0.000649	CcSEcCtD
Calcipotriol—Rash—Prednisolone—psoriasis	1.91e-05	0.000628	CcSEcCtD
Calcipotriol—Dermatitis—Prednisolone—psoriasis	1.91e-05	0.000628	CcSEcCtD
Calcipotriol—Rash—Hydrocortisone—psoriasis	1.87e-05	0.000614	CcSEcCtD
Calcipotriol—Dermatitis—Hydrocortisone—psoriasis	1.87e-05	0.000613	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—TP53—psoriasis	1.83e-05	0.00198	CbGpPWpGaD
Calcipotriol—Pruritus—Betamethasone—psoriasis	1.79e-05	0.000588	CcSEcCtD
Calcipotriol—Pruritus—Dexamethasone—psoriasis	1.79e-05	0.000588	CcSEcCtD
Calcipotriol—Rash—Triamcinolone—psoriasis	1.76e-05	0.000578	CcSEcCtD
Calcipotriol—Dermatitis—Triamcinolone—psoriasis	1.76e-05	0.000577	CcSEcCtD
Calcipotriol—VDR—Gene Expression—CARM1—psoriasis	1.75e-05	0.00189	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.75e-05	0.00188	CbGpPWpGaD
Calcipotriol—Paraesthesia—Methotrexate—psoriasis	1.66e-05	0.000544	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—CARM1—psoriasis	1.63e-05	0.00176	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Prednisone—psoriasis	1.63e-05	0.000534	CcSEcCtD
Calcipotriol—Rash—Dexamethasone—psoriasis	1.6e-05	0.000524	CcSEcCtD
Calcipotriol—Rash—Betamethasone—psoriasis	1.6e-05	0.000524	CcSEcCtD
Calcipotriol—Dermatitis—Betamethasone—psoriasis	1.6e-05	0.000524	CcSEcCtD
Calcipotriol—Dermatitis—Dexamethasone—psoriasis	1.6e-05	0.000524	CcSEcCtD
Calcipotriol—Pain—Methotrexate—psoriasis	1.58e-05	0.000518	CcSEcCtD
Calcipotriol—Pruritus—Prednisone—psoriasis	1.56e-05	0.000512	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.52e-05	0.00164	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—PPARG—psoriasis	1.52e-05	0.00164	CbGpPWpGaD
Calcipotriol—Rash—Prednisone—psoriasis	1.39e-05	0.000457	CcSEcCtD
Calcipotriol—Dermatitis—Prednisone—psoriasis	1.39e-05	0.000456	CcSEcCtD
Calcipotriol—Hypersensitivity—Methotrexate—psoriasis	1.36e-05	0.000446	CcSEcCtD
Calcipotriol—Pruritus—Methotrexate—psoriasis	1.3e-05	0.000428	CcSEcCtD
Calcipotriol—Rash—Methotrexate—psoriasis	1.16e-05	0.000382	CcSEcCtD
Calcipotriol—Dermatitis—Methotrexate—psoriasis	1.16e-05	0.000381	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—CAT—psoriasis	1e-05	0.00108	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—APOE—psoriasis	7.78e-06	0.000839	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—PPARG—psoriasis	7.3e-06	0.000788	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PPARG—psoriasis	6.77e-06	0.000731	CbGpPWpGaD
